Answers are grounded in this paper and cite their sources.
Vaccine-induced immune thrombotic thrombocytopenia (VITT), a rare but life-threatening complication of adenoviral vaccination against COVID-19, has been reported almost entirely following the first dose. Krzywicka and colleagues report on 124 patients with VITT in a multinational registry diagnosed after dose 2; no specific events were observed after dose 1. These patients had early presentation, and two of the patients died.
No takes yet. Share an insight, caveat, or question.
Krzywicka et al. (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: